SCHEMBL30725852

SCHEMBL30725852

C[Si](C)(C)CCOCn1nc(-c2cccnc2)c2cc(NC(=O)c3ccc(C#N)cc3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
ABL1 P00519 1/20 0.45
PDGFRB P09619 1/20 0.45
BCR P11274 1/20 0.45
PDGFRA P16234 1/20 0.45
PRKCA P17252 1/20 0.45
LRRK2 Q5S007 2/20 0.43
TEK Q02763 4/20 0.41
MAPT P10636 3/20 0.41
RXFP1 Q9HBX9 1/20 0.40
BRAF P15056 1/20 0.40
ROCK2 O75116 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
ITK Q08881 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29172520 1.00 CYP11B1 (0.46) CYP11B1CYP11B2ABL1PDGFRBBCR
SCHEMBL29172518 0.93 BRAF (0.48) ABL1PDGFRBBCRPDGFRAPRKCA
SCHEMBL30725845 0.93 BRAF (0.48) ABL1PDGFRBBCRPDGFRAPRKCA
SCHEMBL29172524 0.90 PRKCA (0.43) CYP11B1CYP11B2ABL1PDGFRBBCR
SCHEMBL30725853 0.90 CYP11B1 (0.47) CYP11B1CYP11B2ABL1PDGFRBBCR
SCHEMBL29172517 0.90 CYP11B1 (0.47) CYP11B1CYP11B2ABL1PDGFRBBCR
SCHEMBL29172481 0.87 NAMPT (0.43) CYP11B1CYP11B2ABL1PDGFRBBCR
SCHEMBL29172485 0.85 BRAF (0.45) CYP11B1CYP11B2ABL1BCRTEK
SCHEMBL30725867 0.85 BRAF (0.45) CYP11B1CYP11B2ABL1BCRTEK
SCHEMBL29172522 0.85 L3MBTL1 (0.43) LRRK2MAPTRXFP1GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117186066-A Indazole ALK5 inhibitor and preparation method and application thereof 中国药科大学 2023-12-08 CN disclosed